Meningioma: Current State and Future Directions

Dr Lukas discusses the current state and future clinical advances in the treatment and management of meningiomas. 

Dr Rimas V. Lukas has reported the following commercial interests:
Personal compensation for consulting, serving on a scientific advisory board, speaking,
or other activities with AbbVie, NewLink Genetics, ReNeuron, Monteris, and the American Physician
Institute; Personal compensation in an editorial capacity for Medlink Neurology and EBSCO.
Honoraria for developing and presenting CME board review content for American
Physician Institute.